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Panels of experts with specialized knowledge and experience are often convened
to identify and analyze information relevant for risk assessments of GM crops.
A perspective on the use of such scientific expert panels is shared here based on
panels convened to inform the regulatory strategy for three separate projects developing
GM crops for cultivation in Africa: a nutritionally enhanced sorghum, an insect resistant
cowpea, and a virus resistant cassava. The panels were convened specifically to
consider the risks associated with gene flow from a genetically modified (GM) crop
to naturally occurring ‘wild’ relatives of that crop. In these cases, the experts used
problem formulation to identify effects that regulatory authorities may consider to be
harmful (“harms”) and formulate plausible scenarios that might lead to them, and the
availability of information that could determine the likelihood of the steps in the pathway.
These panels and the use of problem formulation worked well to gather the existing
information and consider the likelihood of harm from gene flow in centers of diversity.
However, one important observation from all of these cases is that it is outside the remit
of such scientific expert panels to make decisions dependent on policy, such as which
harms should be considered and what information should be considered essential in
order for a regulatory authority to make a decision about the acceptable level of risk.
These experiences of expert panels to inform GM crop risk assessment demonstrate
the challenge of integrating science and policy for effective regulatory decision-making.
Keywords: GM crop regulation, risk assessment, problem formulation, risk characterization, expert panels, gene
flow, centers of diversity
INTRODUCTION
The cultivation of genetically modified (GM) crops can bring significant benefits to farmers, the
environment and society (e.g., Klümper and Qaim, 2014; Brookes and Barfoot, 2017a,b). GM crops
are also strictly regulated because of concerns that their use may have detrimental effects on human
health and the environment (Jaffe, 2004). There is a long-standing concern, however, that ‘over-
regulation’ of the products of biotechnology is preventing the realization of the benefits they offer,
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particularly in developing countries (e.g., Paarlberg, 2006).
Central to this problem is the need to discern whether and how
scientific and non-scientific evidence should be used in regulatory
decision-making (Adenle et al., 2018). In particular, assessment
of environmental risk is often hindered by the absence of clear
policy objectives that are needed to guide the interpretation of
scientific data (Evans et al., 2006).
In this perspective, we share observations from our experience
with three separate scientific expert panels convened to
inform risk assessments on the specific issue of gene flow
from GM sorghum, cowpea, and cassava to wild plants in
various parts of Sub-Saharan Africa. We found that such
panel discussions and the use of problem formulation are
first excellent forums for organizing existing knowledge in
order to predict the likelihood of harmful effects, at least
in these cases of transgene introgression into wild species,
including in the crop’s centers of diversity; and second,
useful for identifying scientific uncertainty associated with
the predictions, and studies that could be conducted to
reduce that uncertainty. In addition to these, the most
notable observation on these expert panels is the need to
discern scientific and non-scientific information, as was evident
in these discussions. Outside the remit of such panels is
decision-making responsibilities that include definitions of
harm and judging the sufficiency of scientific knowledge
and the extent to which uncertainties must be reduced
for decision-making. Hence, the panels demonstrate the
challenge of integrating scientific and non-scientific policy-
related information in decision-making and the need for clear
policy in order to avoid an unnecessary quest for more and more
scientific information.
THE PROBLEM: ASSESSING THE RISKS
FROM GENE FLOW TO WILD RELATIVES
The potential for harmful effects following gene flow from
GM crops to sexually compatible wild relatives was among the
earliest environmental concerns associated with GM crops (e.g.,
Dale, 1992). Frameworks to assess the risks from gene flow to
wild relatives are not defined as well as those to assess some
other risks, such as the use of substantial equivalence for food
safety (e.g., Novak and Haslberger, 2000; König et al., 2004),
or the tiered approach that is used for non-target organism
assessment (e.g., Garcia-Alonso et al., 2006; Romeis et al.,
2008). Early gene flow studies were concerned more with the
frequency and distance of gene flow (e.g., Timmons et al., 1995;
Ellstrand et al., 1999; Ellstrand, 2003), although these studies
rarely lead to a risk conclusion without a need to consider the
consequences. It is more difficult and few attempts have been
made to design frameworks and studies that assess the more
complex questions about consequences of gene flow (although,
see Snow et al., 2003; Raybould and Cooper, 2005; Sasu et al.,
2010).
The crops which were the subject of the expert panel
discussions included sorghum (Sorghum bicolor) and cowpea
(Vigna unguiculata subsp. unguiculata), which are staple crops
being developed for use in, or close to, their center of
diversity in Africa. The center of diversity can be defined as
the geographic area where there is a high level of in situ
genetic diversity for a crop species. The third crop, cassava
(Manihot esculenta), is a staple crop but its center of diversity
is not in Africa; however, there is one known, introduced
compatible wild (free-living) relative of cassava (M. glaziovii)
found in Africa. These three crops are the subject of continuing
research to use genetic engineering to introduce traits with
the potential to dramatically improve value for farmers and
consumers in Africa: sorghum with multiple genes for nutritional
enhancement traits (increased vitamin A, iron, zinc, lysine,
and threonine) in East and West Africa; cowpea producing
Cry1Ab that confers resistance to the pod borer in West
Africa; and cassava using RNA interference (RNAi) technology
for cassava brown streak virus (CBSV) resistance in East
Africa.
The first regulatory scrutiny of these and similar GM crops
being developed by international non-profit, philanthropic or
governmental development organizations, is likely to occur in
countries where regulatory authorities have limited experience
of and resources for evaluating the technology, including risk
assessment. It is important, therefore, that risk assessments
exploit existing knowledge and not default to requirements
for new data when it is not necessary for effective decision-
making, as is an unfortunate trend in cases where there are
more resources. To this end, the first of these panels, comprising
experts in risk assessment, gene flow, sorghum biology and
sorghum as a crop in Africa was assembled in 2008 by the
Africa Biofortified Sorghum project to discuss how to assess
the risks from cultivating nutritionally enhanced sorghum in
the center of sorghum diversity. Sorghum is a major crop in
sub-Saharan Africa and its center of diversity is in Ethiopia
and Sudan (Harlan, 1971); therefore, if GM sorghum is to be
grown in Africa, the question of risks from gene flow in centers
of origin and diversity has to be addressed. It is important
to note that the panel was not asked to make a decision
about the risks, but to share their experience and expertise
within the framework of problem formulation and likelihood
assessment.
The sorghum panel provided the template for the composition
and method of working for the subsequent panels on cowpea
and cassava in East Africa. Each panel selected by the
projects consisted of approximately six scientific experts
(not regulators), half being experts from Africa, who had
expertise in the area of GM crop risk assessment, gene
flow, or the biology and ecology of the crop and its
relatives. Although other panel members differed among
panels, the authors of this perspective participated on each
of these panels, and the three discussions were facilitated
by author K. Hokanson. The sorghum and cowpea panels
met in St. Louis, MO, United States in 2008 and 2010,
respectively; the cassava panel met in Mombasa, Kenya
in 2015. Each panel more-or-less followed the process of
problem formulation as outlined below. More details of these
potential products and of the panel discussions are described
in previous publications (sorghum: Hokanson et al., 2010;
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cowpea: Huesing et al., 2011; and cassava: Hokanson et al.,
2016).
PROBLEM FORMULATION AND
LIKELIHOOD ASSESSMENT USING
EXISTING INFORMATION
Problem formulation for assessing the risks from using GM
crops may be regarded as a method for formulating and
proposing tests of hypotheses that are relevant for making
decisions concerning particular products (Raybould, 2006). At
their most conservative, the hypotheses under test are similar for
all crops: growing genetically modified crop X in region Y will
not result in harmful effect Z. Less conservative hypotheses are
that growing the crop poses no unacceptable risk. Corroboration
of a hypothesis of no harm provides rigorous corroboration of
a hypothesis of no unacceptable risk, whereas falsification of a
hypothesis of no harm does not necessarily indicate unacceptable
risk – the risk may be acceptable depending on, for example, the
opportunities presented by cultivating the crop (Sanvido et al.,
2012). Hypotheses of no harm or of no unacceptable risk are
called “risk hypotheses.”
After problem formulation, the risks can be characterized by
testing the risk hypotheses with existing information. ‘Testing’
a hypothesis does not necessarily require experimentation.
If a hypothesis is corroborated or falsified using available
existing information with sufficient certainty for decision-
making, no further testing of that hypothesis ought to be
necessary for the purposes of risk assessment; however, there
may be interest in testing the hypothesis for other reasons.
If a hypothesis requires further testing for decision-making,
problem formulation devises testing through new studies or
observations, or by gaining access to previously unavailable
existing information. Because risk assessment is a decision-
making tool, and not basic research, simple, rigorous tests
of hypotheses under unrealistically conservative conditions are
generally preferred. If a risk hypothesis is falsified under
conservative testing, a further round of problem formulation
may lead to a decision to conduct further testing under more
realistic conditions, or to complete the risk assessment based on
the conservative tests (Raybould, 2006).
The expert panels followed the principles of problem
formulation outlined above as a means to gather and deliberate
about existing information. First, the panels decided what effects
of gene flow from the crop to a wild relative should might
be regarded as environmental ‘harm’ by a regulator. (‘Harm’
in this sense is synonymous with ‘adverse effects’ as used in
the methodology outlined for risk assessment under Annex
III of the Cartagena Protocol on Biosafety.) Determination of
which harms are to be considered in regulatory risk assessment
is a matter of policy and would normally be derived from
protection goals; that is, the overall objectives of the policy
that the regulations are intended to deliver (e.g., Hommen
et al., 2010; Garcia-Alonso and Raybould, 2014). As the panels
were operating independently of any specific policy guidance,
determination of harm was based on precedent from existing
risk assessments and assumptions about change that might
be regarded as detrimental to the environment, and as such
represented an opinion of the experts rather than a regulatory
determination. For these panel discussions, harms were defined
necessarily to carry out the problem formulation; they were
certainly not intended to influence the regulatory policy of any
country.
The panels identified a similar list of harms to consider
further for each of the crops, which can be summarized as
arising from two basic mechanisms: (1) genetic changes resulting
from selective sweeps or genetic swamping; and (2) demographic
changes resulting from changes in species abundance or an
increase in toxicity or decrease in nutritional quality of the
wild relative (Figure 1). The harm due to the first mechanism
would be a loss of valuable genetic diversity in the crop gene
pool. From the second mechanism, harms included reduced
abundance or diversity of valued species (native flora and fauna
or domestic animals) or reduced crop yield or quality through
loss of ecosystem services. Loss of valuable ecological functions
underlying other ecosystem services was also postulated, but
more precise harms were not specified. The panels recognized
that the presence of transgenes in wild populations in the
absence of any other genetic or demographic effects might be
considered of concern on religious or cultural grounds; however,
these harmful effects were not considered further as science
has little or no contribution to characterizing risk in such
circumstances other than to indicate whether or not gene flow
is conceivable.
Defining the harms allowed the panels’ deliberations to
concentrate on elaborating the steps that would need to occur for
a harm to be realized; the series of steps leading to a particular
harmful effect is called a “conceptual model” or “pathway
to harm.” A highly simplified summary of the two principal
pathways considered by the panels is depicted (Figure 1).
Without this focus on defined harmful effects, it is likely that
the panels would have attempted a comprehensive description
of all possible effects following release of the particular GM
crop, which is neither an efficient nor effective method of risk
assessment.
Once the pathways to harm had been described, the likelihood
of each step being realized was evaluated by the panels using
existing knowledge. A likelihood assessment determines the
degree of chance that harm, or a step leading to harm, occurs
OGTR (2009). Ascribing a likelihood to a step, e.g., highly
unlikely, unlikely, likely, is in effect a determination of the
confidence in the corroboration or falsification of the hypothesis
that the particular step in the pathway will not occur. In theory,
once a single step in the pathway is deemed as highly unlikely
with sufficient confidence, the risk via the pathway can be
designated as negligible. However, just as harm and acceptable
risk are matters for policy, so is the determination that a
hypothesis has been corroborated with sufficient rigor. Hence,
even though a particular step in a pathway is deemed unlikely,
the discussion of subsequent steps usually continues so that
risk could be determined as the cumulative probability of every
step being realized in sequence. For each crop, the cumulative
probability along each pathway suggests that harm was unlikely
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FIGURE 1 | Simplified pathways to harm resulting from gene flow to a wild relative. Gray boxes indicate the harm (adverse effect).
to occur via gene flow from the respective crop to its wild relative
(Hokanson et al., 2010, 2016; Huesing et al., 2011).
PROBLEM FORMULATION AND
LIKELIHOOD ASSESSMENT IN
CENTERS OF DIVERSITY
In these panel discussions, the harmful effects as defined were the
same whether or not the crop is grown in its center of diversity
(as for sorghum and cowpea) or not (as for cassava), and the
process of problem formulation and risk assessment is the same
in all cases, although the pathways may be different and more or
less probability may have been assigned to different steps. That
is to say, different methodology was not necessary to conduct
risk assessment for a GM crop in the center of diversity. When
conducting risk assessment for GM crops in centers of diversity,
the most important thing is to define the harmful effects at the
outset. In centers of diversity the primary (although not the only)
concern is likely to be the protection of a genetic resource. If this
is the case, it is essential that a plausible mechanism by which that
harm may arise from growing the specific GM crop is set out, as
it was in the panel deliberations.
The harms and the pathways that can lead to their
manifestation as defined by the expert panels are a useful start
for any discussion of the risks of crop to wild relative gene
flow. Particularly in centers of diversity, a loss of diversity in
the gene pool of the crop resulting from gene flow has an
increased probability than elsewhere simply because compatible
wild relatives and a high level of valuable diversity are usually
found in a crop’s center of diversity. The cassava panel used
their knowledge about the center of diversity for cassava to
determine that ‘loss of genetic diversity’ is unlikely if the GM
cassava is grown in Africa because valuable genetic diversity in
wild relatives is not found in Africa. In the case of sorghum
and cowpea, intended to be grown in (or close to) its center of
diversity in Africa, it was also important to consider other parts
of the conceptual model that would lead to this harm, that being
the likelihood of steps for genetic swamping or selective sweeps
to occur. The panels agreed, based on their knowledge, that in
these cases these steps in the pathway leading to a loss of genetic
diversity as a resource for all three crops are also not likely. In
Frontiers in Plant Science | www.frontiersin.org 4 August 2018 | Volume 9 | Article 1157
fpls-09-01157 August 7, 2018 Time: 8:51 # 5
Hokanson et al. Need for Science and Policy
other words, the probability of genetic swamping or selective
sweeps is ‘no more likely’ than with non-GM sorghum, cowpea,
or cassava counterparts.
CONSIDERING OPTIONS FOR FURTHER
TESTING
After reviewing the estimates of the likelihood of harm based
on existing knowledge, in each case, the panels were asked to
consider data gaps and ways in which they could be filled. It
should be noted that in each case, the panels determined that the
risk hypothesis in the first step in the pathway – ‘gene flow to
wild relatives will not occur’ – could be falsified based on existing
knowledge. In other words, for each crop there is some evidence
to suggest that gene flow can occur between the crop and the
wild relative in question. Although the existing quantification of
frequency or distance of gene flow was not necessarily precise, the
panels thought in each case that it would be low, and additional
studies to further test the risk hypothesis, e.g., more precisely
measure gene flow, would not usefully reduce uncertainty for the
purposes of risk assessment.
Despite ultimately finding that the potential for harm was
unlikely via any pathway, based on information considered
relevant in all of the steps, each panel suggested options for
experimentation to further test hypotheses derived from the
pathways. These options are summarized in Table 1. These were
hypotheses that the panels did not necessarily think ‘should
be’ tested, but that ‘could be’ tested with a carefully designed
experiment, although the panels stopped short of describing
details of experimental designs. The relevant project team was
left to decide whether to undertake these studies depending on
its own priorities, including the a priori interpretation of what
might be required in the country where the project would apply
for an approval.
USING SCIENTIFIC EXPERT PANELS IN
RISK ASSESSMENT
Expert panels proved an effective means to allow experts in
different disciplines, and sometimes at odds about their initial
concepts of risk, to work collegiately to organize existing
knowledge into effective risk assessments. Experts in risk
assessment could show how to use problem formulation and
keep discussions focused on topics essential for risk assessment,
while experts on gene flow, crop biology and the ecology of the
wild relatives could provide the knowledge necessary to test the
hypotheses arising from problem formulation. There was great
opportunity for knowledge exchange: local experts could learn
risk assessment methods, while risk assessment experts could
learn how to integrate local ecological and agronomic knowledge
into their conceptual models. Finally, expert panels excel in the
ability to suggest options for further work, although this can
create problems (see below).
A significant disadvantage in these expert panel deliberations,
particularly such as these convened to advise the projects, was
the limited input of policy to direct the scientific discussions.
First, there is the problem of defining harmful effects. For
the purposes of these panel discussions, the scientists on the
panels had to define harm based on precedent and inference.
This means that the panels may not have considered effects
that some future regulator may think are important or which
may be defined within specific regulatory guidelines or statutes.
Conversely, in setting out what could be considered harmful
effects, the opinions of the panels could inadvertently influence
TABLE 1 | Probability for harm related to gene flow from GM sorghum, cowpea, and cassava into wild relatives in Africa based on existing information, and options for
further testing of risk hypotheses.
Nutritionally enhanced sorghum
Sorghum bicolor
Insect resistant cowpea Vigna
unguiculata subsp. Unguiculata
Virus resistant cassava Manihot
esculenta
Center of
diversity
Ethiopia–Sudan region of Africa West Africa New World – Mexico/Brazil
‘Wild’ relative
known to
hybridize
Sorghum bicolor subspecies Vigna unguiculata subsp. unguiculata var.
spontanea
Manihot glaziovii
Probability for
harm
Unlikely Unlikely Unlikely
Option for further testing:
Proposed
Hypothesis
Introgression of transgenes from nutritionally
enhanced sorghum will not increase the
survival or reproduction of crop x wild relative
hybrids above existing levels
An increase in seed production does not
result in an increase in the abundance of wild
cowpea (in the event that introgression of Bt
genes protected wild cowpea from insect
damage and led to greater seed production)
CBSV does not limit seedling recruitment
(populations size) of Manihot glaziovii
(introgression of virus resistance could not
increase the population size of the cassava
wild relative)
Proposed Test Compare fitness-related characters in GM
sorghum x wild hybrids and non-GM
sorghum x wild hybrids
Observe the number of plants that survive to
reproduce in plots sown with increasing seed
densities
Determine whether CBSV-infected seedlings
of M. glaziovii survive at significantly lower
rates than non-infected seedlings, even under
a high-dose exposure to the virus
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regulatory policy in countries where the crops are intended to be
grown. Scientific expert panels are also commonly convened by
the regulatory authorities. When that is the case, the regulatory
policies governing the deliberations should be clear, although
this remains a challenge for fledgling regulatory systems such as
those in the countries targeted by the three projects discussed
here. Even where there are well developed regulatory systems,
harms derived from protection goals are not always well defined
(Garcia-Alonso and Raybould, 2014).
The more significant challenge encountered by the absence of
policy in these types of panel discussions, however, is to know
whether or when a hypothesis has been tested with sufficient
rigor for decision-making; that is, whether scientific uncertainty
is unacceptably high and needs to be reduced. In the absence of
such policy guidance, an expert scientific panel can always suggest
further studies because no hypothesis can ever be proved and
some uncertainty always remains. This problem is perpetuated
among research scientists based on a misconception that ‘science-
based’ risk assessment means ‘research-based’ risk assessment;
that is, existing knowledge is never sufficient for decision-
making and new studies must always be required. Having seen
suggestions for further work, regulators may be reluctant to say
that the work is not necessary.
Regulators to whom the remit for decision-making does fall,
i.e., those responsible to use the scientific knowledge gathered
for the risk assessment in order to make a decision about the
acceptable level of risk, should be aware that scientific experts
can inadvertently drive regulatory policy toward acquisition of
new or ‘nice-to-know’ data through an emphasis on scientific
uncertainty. The aim should be to maximize the use of existing
knowledge and only require new data that are necessary or ‘need-
to-know’ in order to reduce uncertainty to a level necessary
for decision-making (see also Romeis et al., 2009). The types
of complex ecological and evolutionary studies that might be
designed to reduce uncertainty about the likelihood of harmful
effects from gene flow, such as loss of genetic diversity in
centers of diversity, are difficult to execute and are apt to
lack the precision that would improve decision-making, even
when precise quantitative decision-making criteria are defined
by policy. An inclination to exercise excessive precaution risks
a waste of scarce resources, and might even stop progress
on potentially beneficial projects if the studies proposed are
too costly or complex and unworkable. Yet, decision-makers
will always face the challenge of balancing precaution with
uncertainty. Problem formulation and hypothesis testing are
useful tools to find and describe this balance.
CONCLUSION
Our experience working with expert panels to inform GM crop
risk assessment in centers of diversity leads us to conclude
that panels such as these are valuable for gathering and
organizing existing information so that it can be considered
in risk assessments of GM crops, and problem formulation is
a highly effective tool to facilitate this. However, these panel
discussions also demonstrated that, while scientific expertise is
essential in order to provide the knowledge necessary for making
good decisions, science cannot operate in a policy vacuum.
Risk assessors need definitions of harm, otherwise they will be
forced into an almost limitless task of trying to characterize
every conceivable effect of growing a particular GM crop.
Furthermore, without knowledge of how decisions will be made,
and in particular how the sufficiency of data will be determined,
scientists will always be able to suggest new studies, and less
experienced regulators may feel pressure to accept that the studies
are necessary. Hence, without policy, science may produce data
that are unnecessary for risk assessment and data that are not
very interesting for basic research (e.g., Raybould, 2010). Suitable
integration of scientific and non-scientific factors will be vital
for maintaining functioning regulatory systems, especially in
developing countries. With resources of all sorts often being
severely limited in developing countries, clear policy is needed
to ensure that they are used effectively.
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